Sex And The Single Drug, Case Western Reserve University Study 6/28/2010
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Closes $15 Million Registered Direct Offering to Fund LibiGel(R) for Female Sexual Dysfunction 6/24/2010
More...
|
FDA Panel Votes Against NDA For Boehringer Ingelheim Corporation's 'Female Viagra' Flibanserin 6/21/2010
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel(R) 6/21/2010
More...
|
Bayer AG (BAY.F) Bags Rights to Female Sex Dysfunction Drug from EndoCeutics 5/6/2010
More...
|
Boehringer Ingelheim Corporation (JOBS) Drug Shown to Kindle Female Sex Drive 11/16/2009
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Says Lead Drug Safe in Late-Stage Study 8/13/2009
More...
|
Palatin Technologies (PTN) Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 8/12/2009
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) to Continue Safety Study for Lead Drug; Company Seeks to Submit NDA by 2010-End or Early 2011
6/17/2009
More...
|
Viagra Helpful to Women on Antidepressants, Indiana University Study Finds 7/23/2008
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Release: New Medical Research Study for Women Who’ve Lost That Loving Feeling 6/3/2008
More...
|
Testosterone Spray Improves Sexual Satisfaction Slightly in Premenopausal Women But So Does Placebo 4/15/2008
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA 3/19/2008
More...
|
Female G Spot Can Be Located With Ultrasound 2/22/2008
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study 1/7/2008
More...
|
Zestra Laboratories, Inc. Release: Zestra(R) Improves Female and Partner Sexual Satisfaction
11/15/2007
More...
|
BioSante Pharmaceuticals, Inc. (BPA) To Present Validation Data Required for Development of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction 10/4/2007
More...
|
Palatin Technologies (PTN) Reports Positive Data from an At-home Study of Pre- and Postmenopausal Women with Female Sexual Arousal Disorder Treated with Bremelanotide 9/27/2007
More...
|
Intra-Cellular Therapies, Inc. Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction 9/18/2007
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Announces FDA Clarity on Development of LibiGel® (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction 9/11/2007
More...
|
Testosterone Patch Benefits Women with Low Sexual Desire 8/15/2007
More...
|
Topical Testosterone Cream Does Not Increase Sexual Drive in Female Cancer Survivors 5/2/2007
More...
|
Patch 'to Boost Female Sex Drive' 3/28/2007
More...
|
Zestra Laboratories, Inc. Completes Large-Scale Study of Non-Prescription Zestra(R) Feminine Arousal Fluid in Women with Mixed Sexual Dysfunction 3/15/2007
More...
|
Antares Pharma, Inc. (ANTR) ATD™ Formulation Enters Phase III Study 1/2/2007
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Initiates Phase III Study Of LibiGel(R) In The Treatment Of Female Sexual Dysfunction 12/28/2006
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals®, Inc. Complete Enrollment in Pre-Menopausal Cohort Of A Phase 2 Clinical Trial Evaluating Bremelanotide In Pre- And Post-Menopausal Female Sexual Dysfunction Patients 12/20/2006
More...
|
Health Canada Warns Consumers Not To Use Natural Sex Enhancer Libidus Due To Potential Health Risks 9/20/2006
More...
|
Labor May Not Harm Post-Pregnancy Sexual Function 9/11/2006
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals®, Inc. Report Results Of A Clinical Study Evaluating Bremelanotide In Post-Menopausal Female Sexual Dysfunction Patients 8/3/2006
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals®, Inc. Announce Publication Of The Results Of A Clinical Study Evaluating Bremelanotide In Premenopausal Female Sexual Dysfunction Patients 6/22/2006
More...
|
Pharma Companies Creating Diseases To Sell Their Medicines 4/11/2006
More...
|
Rare Sexual Syndrome Needs More Research 3/24/2006
More...
|
King Pharmaceuticals®, Inc. And Palatin Technologies (PTN) Release: Bremelanotide Clinical Trial Results Presented At The International Society For The Study Of Women's Sexual Health 2006 Annual Meeting 3/9/2006
More...
|
Zestra Laboratories, Inc. Release: Clinically Proven All-Natural Feminine Product To Be Part Of Women's Conference 3/1/2006
More...
|
USAN And World Health Organization Approve Generic Name Bremelanotide For PT-141, First In A New Class Of Experimental Treatments For Sexual Dysfunction 2/8/2006
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals®, Inc. Initiate Phase IIb Clinical Trial Evaluating PT-141 In Patients Suffering From Female Sexual Arousal Disorder 2/7/2006
More...
|
VIVUS, Inc. (VVUS) Completes Enrollment In Phase 2b Study Of ALISTA(TM) For Treatment Of Female Sexual Arousal Disorder 12/7/2005
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Comments On Updated FDA Guidance For Testosterone Therapy 11/2/2005
More...
|
FDA Reports Positive New Antares Pharma, Inc. (ANTR) Guidance On Testosterone Therapies For Female Sexual Dysfunction 11/2/2005
More...
|
QualiLife Pharmaceuticals, Inc. Release: National Institutes of Health (NIH) Accept Clinical Study Of Zestra (TM) For Women; Sexual Medicine Experts Will Enroll 200 Women At 16 Research Sites In The Only Registered Study To Directly Address Women's Sexual Problems 7/20/2005
More...
|
Sexual Problems Common In Women With Heart Disease 7/14/2005
More...
|
No Link Found Between Low Androgen Levels And Low Sexual Function In Women 7/6/2005
More...
|
Genes Affect Women's Ability To Reach Orgasm 6/8/2005
More...
|
NexMed (NEXM) Announces Positive Femprox Study Results At American Urological Association Annual Meeting In San Antonio 5/23/2005
More...
|
VIVUS, Inc. (VVUS) Announces Presentation Of ALISTA(TM) Clinical Data For The Treatment Of Female Sexual Arousal Disorder 5/23/2005
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals®, Inc. Announce Publication Of Clinical Study Results Of Co-Administration Of PT-141 And Viagra(R) 4/18/2005
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals, Inc. - Sterile Products Operations (KG) Announce Formation Of Scientific Advisory Board For PT-141 4/7/2005
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals, Inc. - Sterile Products Operations (KG) To Webcast PT-141 Symposium 3/15/2005
More...
|
Ardana Bioscience Announces Successful Completion Of IPO 3/4/2005
More...
|
VIVUS, Inc. (VVUS) Announces Proposed Public Offering Of Common Stock 2/23/2005
More...
|
Women: Orgasm In A Spray Undergoes Successfull Trials 2/10/2005
More...
|
Clinical Trial Demonstrates Improved Sexual Desire In Women With Low Libido After Treatment With VIVUS, Inc.' (VVUS) Testosterone Spray 2/9/2005
More...
|
Palatin Technologies (PTN) And King Pharmaceuticals, Inc. (KG) Report Positive Results Of A Phase 2A Pilot Clinical Study Evaluating PT-141 In Female Sexual Dysfunction Patients 2/8/2005
More...
|
Palatin Technologies (PTN) Completes Enrollment In PT-141 Clinical Trials For Female Sexual Dysfunction And Male Erectile Dysfunction 1/13/2005
More...
|
Ligand Pharmaceuticals Inc. (LGND) Announces TAP Pharmaceutical Products Inc. Extension Of R&D Collaboration Through June 2006 12/29/2004
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Comments On Procter & Gamble's (PG) Decision To Withdraw And Resubmit NDA For Testosterone Patch 12/23/2004
More...
|
Novavax, Inc. (NVAX) Updates Clinical Strategy For Testosterone Therapy ANDROSORB 12/6/2004
More...
|
FDA Advisers Vote Against Procter & Gamble's (PG) Female Sex Drug 12/3/2004
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Stock Plunges On News That The FDA Will Probably Not Clear Rival Procter & Gamble's (PG) Testosterone 12/3/2004
More...
|
Endocrine Society Calls For Clinical Guidelines On Androgens For Women 12/2/2004
More...
|
FDA To Review P&G Female Sex Dysfunction Drug 12/1/2004
More...
|
VIVUS, Inc.'s (VVUS) Testosterone MDTS For Female Sexual Dysfunction Completes Phase 2 Clinical Study 11/16/2004
More...
|
NexMed (NEXM) Closes Enrollment For 400 Patient Femprox(R) Study 11/15/2004
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Release: First Transdermal Testosterone Gel To Significantly Increase Sexual Activity In Surgically Menopausal Women 11/1/2004
More...
|
Palatin Technologies (PTN) Responds To Competitive Technologies, Inc.'s Demand For Arbitration 10/29/2004
More...
|
Positive Clinical Data In Treating Female Sexual Arousal Disorder From VIVUS, Inc. (VVUS) To Be Featured During ISSWSH 10/28/2004
More...
|
Cellegy Pharmaceuticals (CLGY) Release: Tostrelle Study Findings To Be Presented At The International Society For The Study Of Women's Sexual Health Annual Meeting October 28 10/28/2004
More...
|
Testosterone Patch Hailed As Female Viagra 10/20/2004
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Announces Study Shows LibiGel Significantly Increases Sexual Activity In Menopausal Women 9/22/2004
More...
|
BioSante Pharmaceuticals, Inc. (BPA) To Hold Conference Call At 8:45 AM ET To Discuss Positive Phase II Data For LibiGel In Female Sexual Dysfunction 9/22/2004
More...
|
Procter & Gamble (PG) Release: FDA Grants Priority Review To An Investigational Treatment For Hypoactive Sexual Desire Disorder In Surgically Menopausal Women 9/21/2004
More...
|
Chinese Women Line Up To Test "Female Viagra" 9/8/2004
More...
|
Cellegy Pharmaceuticals (CLGY) Reports Positive Interim Results Of Phase 2 Study Using Tostrelle(R) Gel To Treat Women With Symptoms Of Sexual Dysfunction 9/8/2004
More...
|
VIVUS, Inc. (VVUS) Initiates Phase 3 Clinical Study For ALISTA 9/7/2004
More...
|
King Pharmaceuticals (KG) And Palatin Technologies (PTN) Announce Strategic Alliance To Jointly Develop And Commercialize PT-141 As An Innovative Treatment For Sexual Dysfunction 8/13/2004
More...
|
VIVUS, Inc. (VVUS) Announces Positive Phase 2 Results For ALISTA In Premenopausal Women With Female Sexual Arousal Disorder 7/14/2004
More...
|
Ligand Pharmaceuticals Inc. (LGND) Earns $1.0 Million Milestone Payment As TAP Pharmaceutical Products Inc. Declares A Second SARM Clinical Candidate; The First Clinical Candidate Selected, LGD122941, Continues Toward IND Filing 7/9/2004
More...
|
Drug May Offer Aphrodisiac For Women 6/29/2004
More...
|
NexMed (NEXM) Initiates 400 Patient Femprox Study Overseas 6/28/2004
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Completes Phase II Clinical Trial For Female Sexual Dysfunction 6/23/2004
More...
|
Patch "Boosts Women's Sex Drive" 5/6/2004
More...
|
P&G Pharmaceuticals, Inc. (PG) Release: Landmark Clinical Study Shows Female Testosterone Patch Significantly Improved Sexual Desire In Surgically Menopausal Women 5/4/2004
More...
|
NexMed (NEXM) To Present Product Pipeline Update At Partnering Summit 3/17/2004
More...
|
Zestra(TM) Female Arousal Fluid Provides Solution For Many Female Sexual Problems; Pfizer Inc. (PFE) Ends Research Of Viagra(R) For Women 3/9/2004
More...
|
NexMed (NEXM) To Initiate 400 Femprox Clinical Study In China For Female Sexual Arousal Disorder (FSAD) 3/2/2004
More...
|
Pfizer Inc. (PFE) Says Inconclusive Results From Viagra Studies In Women Do Not Support Regulatory Filing; Studies Proved Inconclusive 3/1/2004
More...
|
Burrill & Company Announces Closing Of Strategic New Partnership For Acrux Limited 2/17/2004
More...
|
VIVUS, Inc. (VVUS) Expands Sexual Health Product Pipeline Through Deal With Acrux Limited 2/12/2004
More...
|
Tiny Vivus Aims To Rebound With Female Sex Drug 12/31/2003
More...
|
Tiny Vivus Aims To Rebound With Female Sex Drug 12/31/2003
More...
|
Viagra Effective For Some Women 12/29/2003
More...
|
Ligand Pharmaceuticals Inc., (LGND) TAP Pharmaceutical Products Inc. Agree To Extend R&D Collaboration To Discover And Develop Novel SARM Drugs 12/22/2003
More...
|
Norwood Abbey Limited Signs Exclusive License For Its Immunology Intellectual Property In The U.S. Market With TAP Pharmaceutical Products Inc. 11/11/2003
More...
|
Esperion Therapeutics, Inc. (ESPR) Falls On Reports; Drug Data To Be Unveiled 11/4/2003
More...
|